Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
A 200-fold inhibition in the titer of infectious vesicular stomatitis virus (VSV) was produced in cultures of Ly cells treated with 30 reference units of interferon per milliliter. Virus particle production, as measured by VSV particle-associated transcriptase, or nucleocapsid protein was inhibited by a maximum of tenfold. The glycoprotein and membrane protein content was reduced in VSV derived from interferon-treated cells. Thus interferon-treated cells may have produced VSV particles with low infectivity, which may be related to the reduced amount of glycoprotein incorporated into such particles. These findings resemble those reported in interferon-treated cells infected with murine leukemia viruses.
D000818:Animals; D002478:Cells, Cultured; D003673:Defective Viruses / Q000254:growth & development; D006023:Glycoproteins / Q000096:biosynthesis*; D007372:Interferons / Q000494:pharmacology*; D008565:Membrane Proteins / Q000096:biosynthesis*; D051379:Mice; D012367:RNA, Viral / Q000378:metabolism; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development*; D014764:Viral Proteins / Q000096:biosynthesis*; D014779:Virus Replication / Q000187:drug effects*
D006023:Glycoproteins; D008565:Membrane Proteins; D012367:RNA, Viral; D014764:Viral Proteins; D007372:Interferons